Amyl Nitrite is an investigational drug.
There have been 3 clinical trials for Amyl Nitrite.
The most recent clinical trial was a Phase 3 trial, which was initiated on December 21st 2021.
The most common disease conditions in clinical trials are Esophageal Achalasia, Poisoning, and Ventricular Outflow Obstruction. The leading clinical trial sponsors are Johns Hopkins University, Alan H. Tieu, MD, and Mayo Clinic.